Celldex Therapeutics, Inc. — Form D

Celldex Therapeutics, Inc. of HAMPTON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-29. The offering totals $62.5M, of which $62.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2016-11-29
• Form: D
• Accession: 0000905718-16-001790
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $62.5M
• Amount sold: $62.5M
• Investors: 29
• Date of first sale: 2016-11-29
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-275294

Issuer

• Name: Celldex Therapeutics, Inc.
• CIK: 0000744218
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
• Phone: 908-200-7500

Officers, directors & promoters (9)

More

• CIK 744218 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search